1. Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries. (February 2022) Authors: Arango, Celso; Buitelaar, Jan K; Fegert, Jörg M; Olivier, Valérie; Pénélaud, Pierre-François; Marx, Ute; Chimits, Damien; Falissard, Bruno; Barylnik, Julia; Birdeanu, Laura; Bosch, Gert P; Boychevskaya, Julia; Boyev, Igor; Bugán, Enikõ; Bukhanovskaya, Olga; Chaban, Oleg; Dobrescu, Iuliana; Feller... Journal: Lancet Issue: Volume 9:Number 2(2022) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗